Director Appointment

RNS Number : 3665W

Cropper(James) PLC

01 August 2018

 

1 August 2018

James Cropper Plc

(the "Company")

Board Appointment

James Cropper Plc, the advanced materials and speciality paper group today announces the appointment of Dr Andrew Hosty to the Board as a Non-Executive Director with immediate effect. Dr Hosty has been acting as a consultant to the Board since November 2017.

Following a PhD in Materials Technology, Dr Hosty pursued a career in industry culminating in his appointment as CEO of Morgan Ceramics and COO of Morgan Advanced Materials PLC.  Most recently he was founding CEO of The Sir Henry Royce Institute for Advanced Materials, a new £235 million centre for UK advanced materials research and innovation.

Commenting on Andrew's appointment, Mark Cropper, Chairman, said: "We are delighted to welcome Andrew to the Board. He has a significant range of relevant experience from materials science to managing high growth companies in related sectors.  He has much to contribute to James Cropper Plc as it innovates and grows in the coming years and we are very pleased he is joining us at this exciting time".

Additional information to be disclosed pursuant to Schedule 2(g) and Rule 17 of the AIM Rules in relation to Dr Andrew Hosty:

In the past five years, Andrew Joseph Hosty (aged 53) has held the following director roles:

Company Name	Position	From	To
RHI Magnesita Plc	Non-Executive Director	Oct 2017	Current
Rights and Issues Investment Trust Plc	Non-Executive Director	July 2017	Current
mOm Incubators Ltd	Non-Executive Chairman	Mar 2017	Current
Consort Medical Plc	Non-Executive Director	July 2014	Current
Morgan Advanced Materials Plc	Chief Operating Officer	July 2010	Jan 2016
Morgan Technical Ceramics Ltd	Director	July 2000	Oct 2015
Thermal Ceramics UK Ltd	Director	Oct 2010	Oct 2015
Certech International Ltd	Director	Mar 2010	Oct 2015
Morgan Electro Ceramics Ltd	Director	Mar 2010	Oct 2015
British Ceramic Research	Director	Sept 2007	Jun 2015
Fiberweb Ltd	Director	Sept 2012	Nov 2013

Dr Hosty holds 500 ordinary shares of 25p each in the Company, representing 0.005% of the Company's issued share capital.

Other than the information contained within this announcement, there are no further disclosures to be made in relation to Dr Hosty under Rule 17 and Schedule Two, paragraph (g) of the AIM Rules for Companies.

Enquiries:

James Cropper PLC (Aim:CRPR) Isabelle Maddock, Group Finance Director Jim Aldridge, Company Secretary Tel: [phone] www.cropper.com

Stockdale Securities Limited      Robert Finlay, Henry Willcocks      Richard Johnson      Tel:  + 44 (0) 207 601 6100      www.stockdalesecurities.com

 

END

 

 

BOAEASXFDESPEFF